The market leans towards a belief that human cloning won't be possible by 2040.
With a market probability of 42% for cloning a human from live DNA by 2040, the consensus is that this will not be achieved, as indicated by the Pulse verdict of NO. The AI probability also reflects a similar skepticism, suggesting that significant scientific or ethical barriers remain.